Taiwan Investing Millions To Become Regional Pharma R&D Hub And Gateway To Mainland China
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - As part of a four-part plan to develop biotech into its next "trillion-dollar industry," Taiwan is investing hundreds of millions of dollars into the sector and developing specialized science parks and clusters